Marcellino, Bridget K.
Yang, Xiaobao
Ümit Kaniskan, H.
Brady, Claudia
Chen, He
Chen, Karie
Qiu, Xing
Clementelli, Cara
Herschbein, Lauren http://orcid.org/0000-0001-8274-6858
Li, Zhijun
Elghaity-Beckley, Sebastian
Arandela, Joann
Kelly, Brianna
Hoffman, Ronald http://orcid.org/0000-0001-6564-6732
Liu, Jing
Xiong, Yue
Jin, Jian http://orcid.org/0000-0002-2387-3862
Shih, Alan H. http://orcid.org/0000-0003-4618-9673
Funding for this research was provided by:
MPN Research Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Gilead Sciences
Article History
Received: 8 July 2022
Revised: 10 October 2022
Accepted: 13 October 2022
First Online: 29 October 2022
Change Date: 30 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-023-01934-9
Competing interests
: JJ is a cofounder and equity shareholder in Cullgen, Inc. and a consultant for Cullgen, Inc., EpiCypher, Inc., and Accent Therapeutics, Inc. YX is a cofounder, equity shareholder and a current employee of Cullgen, Inc. JL is a current employee of Cullgen, Inc. The Jin laboratory received research funds from Celgene Corporation, Levo Therapeutics, Inc., Cullgen, Inc. and Cullinan Oncology, Inc. The other authors declare no competing interests.